awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35584074-AA3CFC78-E9E2-4657-890A-9F0807E1916B
Q35584074-AA3CFC78-E9E2-4657-890A-9F0807E1916B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35584074-AA3CFC78-E9E2-4657-890A-9F0807E1916B
Targeting angiogenesis with multitargeted tyrosine kinase inhibitors in the treatment of non-small cell lung cancer.
P2860
Q35584074-AA3CFC78-E9E2-4657-890A-9F0807E1916B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35584074-AA3CFC78-E9E2-4657-890A-9F0807E1916B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cb4e8d00e98bbb6e81c2b6ba559444d258e8e8a1
P2860
A phase I and pharmacokinetic study of daily oral cediranib, an inhibitor of vascular endothelial growth factor tyrosine kinases, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer: a study of the Nati